Literature DB >> 2106567

Incorporation, distribution, and turnover of arachidonic acid within membrane phospholipids of B220+ T cells from autoimmune-prone MRL-lpr/lpr mice.

M Tomita-Yamaguchi1, J F Babich, R C Baker, T J Santoro.   

Abstract

The metabolism of AA-containing phosphoglycerides within T cell membranes leads to the generation of second messengers that appear to play a crucial role in transmembrane signal transduction. To test the hypothesis that aberrations in the movement of arachidonoyl-phospholipids are associated with and may potentially contribute to abnormal T cell function, the incorporation, distribution, and turnover of AA within the membrane glycerolipids of cells that are known to exhibit immunoregulatory disturbances was examined. Thy-1+, Ly-1+, L3T4-, Lyt-2-, B220+ T cells from autoimmune MRL-lpr/lpr mice were used as the cellular model. In contrast to control lymph node T cells, which preferentially incorporate labeled AA into phosphatidylcholine (PC), B220+ T cells displayed a predilection for distributing [3H]arachidonate into phosphatidylinositol (PI). The arachidonoyl-phospholipid pools were normal in B220+ T cells. The constitutive turnover of [3H]arachidonoyl-PI was significantly enhanced and that of [3H]arachidonate-PC substantially reduced in B220+ T cell compared with control cells. Using membrane homogenates B220+ T cells demonstrated a functional increase in the levels of lyso-PI. Intact B220+ T cells prelabeled with [3H]myoinositol and cultured in the absence of stimulation with exogenous antigens or mitogens, exhibited increased production of lyso-PI. The data indicate that the preferential formation of [3H]arachidonoyl-PI in B220+ T cells is the result of greatly increased, constitutive PI turnover that appears to be due to a membrane phospholipase A2 activity. It remains possible that disturbances in the movement of arachidonate within phospholipids of B220+ T cells play a role in the expression of aberrant immunological activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106567      PMCID: PMC2187770          DOI: 10.1084/jem.171.3.787

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Regulation of guanylate and adenylate cyclase activities by lysolecithin.

Authors:  W T Shier; J H Baldwin; M Nilsen-Hamilton; R T Hamilton; N M Thanassi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Phospholipid metabolism of stimulated lymphocytes: activation of acyl-CoA:lysolecithin acyltransferases in microsomal membranes.

Authors:  E Ferber; K Resch
Journal:  Biochim Biophys Acta       Date:  1973-02-14

5.  Phospholipid metabolism of stimulated lymphocytes. Composition of phospholipid fatty acids.

Authors:  E Ferber; G G De Pasquale; K Resch
Journal:  Biochim Biophys Acta       Date:  1975-09-19

6.  Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.

Authors:  J W Hadden; E M Hadden; M K Haddox; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

7.  Correlation of in vivo and in vitro phase transitions of membrane lipids in Escherichia coli.

Authors:  P Overath; H U Schairer; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

8.  Effects of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes.

Authors:  J P Kelly; C W Parker
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

9.  Membrane structure-function relationships in cell-mediated cytolysis. I. Effect of exogenously incorporated fatty acids on effector cell function in cell-mediated cytolysis.

Authors:  R Gill; W Clark
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Release of arachidonic acid from human lymphocytes in response to mitogenic lectins.

Authors:  C W Parker; J P Kelly; S F Falkenhein; M G Huber
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  5 in total

1.  Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.

Authors:  Karen Wagner; Bora Inceoglu; Hua Dong; Jun Yang; Sung Hee Hwang; Paul Jones; Christophe Morisseau; Bruce D Hammock
Journal:  Eur J Pharmacol       Date:  2012-12-28       Impact factor: 4.432

Review 2.  Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.

Authors:  Karen Wagner; Bora Inceoglu; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-10       Impact factor: 3.072

3.  High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells.

Authors:  Antonio Catalá-Rabasa; Dorothy Ndagire; Jose Mario Sabio; Maria Fedetz; Fuencisla Matesanz; Antonio Alcina
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

4.  Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.

Authors:  J D Mountz; T Zhou; J Eldridge; K Berry; H Blüthmann
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

5.  Arachidonoyl-phospholipid remodeling in proliferating murine T cells.

Authors:  Michiyo Tomita; Rodney C Baker; Soichiro Ando; Thomas J Santoro
Journal:  Lipids Health Dis       Date:  2004-01-30       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.